Growth Metrics

Pharma-Bio Serv (PBSV) Amortizatization of Intangibles (2023 - 2026)

Pharma-Bio Serv filings provide 4 years of Amortizatization of Intangibles readings, the most recent being $29388.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 28.99% to $29388.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $157211.0, a 2.32% decrease, with the full-year FY2025 number at $169209.0, up 7.19% from a year prior.
  • Amortizatization of Intangibles hit $29388.0 in Q1 2026 for Pharma-Bio Serv, down from $43359.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $43359.0 in Q4 2025 to a low of $29388.0 in Q1 2026.
  • Median Amortizatization of Intangibles over the past 4 years was $39170.0 (2024), compared with a mean of $38668.1.
  • Biggest five-year swings in Amortizatization of Intangibles: increased 8.08% in 2025 and later dropped 28.99% in 2026.
  • Pharma-Bio Serv's Amortizatization of Intangibles stood at $37553.0 in 2023, then grew by 8.08% to $40586.0 in 2024, then increased by 6.83% to $43359.0 in 2025, then tumbled by 32.22% to $29388.0 in 2026.
  • The last three reported values for Amortizatization of Intangibles were $29388.0 (Q1 2026), $43359.0 (Q4 2025), and $42512.0 (Q3 2025) per Business Quant data.